EXHIBIT 23I
DAVID JONES & ASSOC., P.C.
Law Firm
[GRAPHIC OMITTED]
(281) 367-8409 phone
4747 Research Forest Drive (281) 367-8401 facsimile
Suite 180, # 303 [email protected] email
The Woodlands, TX 77381 [email protected] email
September 15, 1999
The Board of Directors
AMIDEX(TM)Funds, Inc., Inc.
26 Broadway, Suite 741
New York, NY 10004
Ladies and Gentlemen:
As counsel to AMIDEX(TM) Funds, Inc. (the "Company"), a corporation organized
under the laws of the State of Maryland, I have been asked to render my opinion
with respect to the issuance of an indefinite number of shares of beneficial
interest of the Company (the "Shares") representing proportionate interests in
the AMIDEX(TM) Israel Technology Fund (the "Fund"). The Shares of the Fund are a
series of the Company consisting of one class of shares, all as more fully
described in the Prospectus and Statement of Additional Information contained in
post-effective amendment # 4 to Registration Statement on Form N-1A, to which
this opinion is an exhibit, to be filed with the Securities and Exchange
Commission.
I have examined the Company's Articles of Incorporation, the Prospectus and
Statement of Additional Information contained in the Registration Statement, and
such other documents, records and certificates as deemed necessary for the
purposes of this opinion.
Based on the foregoing, I am of the opinion that the Shares, when issued,
delivered and paid for in accordance with the terms of the Prospectus and
Statement of Additional Information, will be legally issued, fully paid, and
non-assessable by the Company.
Further, I give my permission to include this opinion as an exhibit to
post-effective amendment # 4 to the Company's Registration Statement on Form
N-1A.
Very Truly Yours,
David D. Jones
Attorney & Counselor at Law
